Longitudinal bone loss in postmenopausal women with primary biliary cirrhosis and well-preserved liver function

Journal of Internal Medicine

Volumn 252, Issue 6, 2002, Pages 537-541

  Ormarsdóttir, Sif ^a   Ljunggren, O ^a   Mallmin, H ^a   Olsson, R ^b   Prytz, H ^c   Loof L ^d  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d CENTRAL HOSPITAL   (Sweden)

Author keywords

Biliary; Bone density; Liver cirrhosis; Oestrogen replacement therapy; Osteoporosis; Postmenopausal

Indexed keywords

CALCIUM; PHOSPHONIC ACID DERIVATIVE; VITAMIN D;

ABSORPTIOMETRY; ADULT; AGED; ARTICLE; BILIARY CIRRHOSIS; BONE DENSITY; BONE MINERAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FEMUR NECK; HORMONE SUBSTITUTION; HUMAN; LIVER DYSFUNCTION; LIVER FUNCTION; LIVER PRESERVATION; LUMBAR SPINE; OSTEOLYSIS; POSTMENOPAUSE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SUPPLEMENTATION; TIME; X RAY;

ADULT; AGED; BONE DENSITY; FEMALE; FEMUR NECK; HORMONE REPLACEMENT THERAPY; HUMANS; LIVER CIRRHOSIS, BILIARY; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; RETROSPECTIVE STUDIES;

EID: 0036915541     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2002.01066.x     Document Type: Article

References (25)

1. Mitchison HC, Malcolm AJ, Bassendine MF, James OFW. Metabolic bone disease in primary biliary cirrhosis at presentation. Gastroenterology 1988; 94: 463-70.
2. van Berkum FNR, Beukers R, Birkenhäger JC, Kooij PPM, Schalm SW, Pols HAP. Bone mass in women with primary biliary cirrhosis: The relation with histological stage and use of glucocorticoids. Gastroenterology 1990; 99: 1134-9.
3. Porayko MK, Wiesner RH, Hay JE et al. Bone disease in liver transplant recipients incidence, timing and risk factors. Transplant Proc 1991; 23: 1462-5.
4. Monegal A, Navasa M, Guanabens N et al. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int 1997; 60: 148-54.
5. Ormarsdóttir S, Ljunggren O, Mallmin H, Brahm H, Lööf L. Low body mass index and use of corticosteroids, but not cholestasis, are risk factors for osteoporosis in patients with chronic liver disease. J Hepatol 1999; 31: 84-90.
6. Eastell R, Dickson ER, Hodgson SF et al. Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology 1991; 14: 296-300.
7. Hillard TC, Whitcroft SJ, Marsh MS et al. Long-term effects of transdermal and oral hormone replacement therapy on postmenopausal bone loss. Osteoporosis Int 1994; 4: 341-8.
8. Lufkin EG, Wahner HW, O'Fallon WM et al. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 1992; 117: 1-9.
9. Crippin JS, Jorgensen RA, Dickson ER, Lindor KD. Hepatic osteodystrophy in primary biliary cirrhosis: Effects of medical treatment. Am J Gastroenterol 1994; 89: 47-50.
10. Olsson R, Mattsson L-Å, Obrant K, Mellström D. Estrogen-progestogen therapy for low bone mineral density in primary biliary cirrhosis. Liver 1999; 19: 188-92.
11. Newton J, Francis R, Prince M et al. Osteoporosis in primary biliary cirrhosis revisited. Gut 2001; 49: 282-7.
12. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-9.
13. Karlsson MK, Gårdsell P, Johnell O, Nilsson BE, Åkesson K, Obrant KJ. Bone mineral normative data in Malmö, Sweden. Comparison with reference data and hip fracture incidence in other ethnic groups. Acta Orthop Scand 1993; 64: 1257-60.
14. Swedish Medical Products Agency. Treatment of Osteoporosis. Workshop 1997.
15. Byvny RL. A Clinical Guide for the Care of Older Women; Primary and Preventive Care, 2nd Edn, Williams and Wilkons, Baltimore, 1996.
16. Tremollieres FA, Pouilles JM, Ribot C. Vertebral postmenopausal bone loss is reduced in overweight women: A longitudinal study in 155 early postmenopausal women. J Clin Endocrinol Metab 1993; 77: 683-6.
17. Clements D, Compston JE, Evans C, Evans WD. Bone loss in normal British women; a 5 year follow-up. Br J Radiol 1993; 66: 1134-7.
18. Hannan MT, Felson DT, Dawson-Hughes B et al. Risk factors for longitudinal bone loss in elderly men and women: The Framingham Osteoporosis Study. J Bone Miner Res 2000; 15: 710-20.
19. Karlsson MK, Obrant KJ, Nilsson BE, Johnell O. Changes in bone mineral, lean body mass and fat content as measured by dual energy X-ray absorptiometry: A longitudinal study. Calcif Tissue Int 2000; 66: 97-9.
20. Melton LJ, Atkinson EJ, O'Connor MK, O'Fallon WM, Riggs BL. Determinants of bone loss from the femoral neck in women of different ages. J Bone Miner Res 2000; 15: 24-31.
21. Lindor KD, Janes CH, Crippin JS, Jorgensen RA, Dickson ER. Bone disease in primary biliary cirrhosis: Does ursodeoxycholic acid make a difference? Hepatology 1995; 21: 389-92.
22. Diamond T, Stiel D, Lunzer M, Wilkinson M, Roche J, Posen S. Osteoporosis and skeletal fractures in chronic liver disease. Gut 1990; 31: 82-7.
23. Hay JE, Lindor K, Wiesner RH, Dickson ER, Krom RAF, LaRusso NF. The metabolic bone disease of primary sclerosing cholangitis. Hepatology 1991; 14: 257-61.
24. Ormarsdóttir S, Ljunggren O, Mallmin H, Michaelsson K, Lööf L. Increased rate of bone loss at the femoral neck in patients with chronic liver disease. Eur J Gastroenterol Hepatol 2002; 14: 257-61
25. Schreiber AJ, Simon FR. Estrogen-induced cholestasis. Clues to pathogenesis and treatment. Hepatology 1983; 3: 607-13.